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Alphaherpesvirus
VaricellovirusMany herpesviruses interfere with the MHC I antigen-processing pathway in order to limit elimination by
cytotoxic T-lymphocytes. For varicelloviruses, the largest subgroup of alphaherpesviruses, two viral proteins
have been reported to downregulate MHC I cell surface expression: UL49.5 for BoHV-1, PRV, and EHV-1 and
the US3 orthologue for VZV. Here, we report that PRV reduces MHC I cell surface expression during infection
in a cell-type-dependent manner. In ST cells, a kinase-active US3 was necessary but not sufﬁcient to
downregulate cell surface MHC I expression, whereas US3 was not required in PK-15 cells and porcine
alveolar macrophages (PAM). MHC I downregulation was not (PAM, ST) or only partly (PK-15) dependent on
UL49.5. In conclusion, we show that the mechanism(s) of PRV-mediated cell surface MHC I downregulation
are cell-type-dependent, with variable roles for US3, UL49.5, and additional, yet unidentiﬁed early viral
proteins.
© 2009 Elsevier Inc. All rights reserved.Introduction
Alphaherpesviruses are a subfamily of herpesviruses containing
closely related pathogens of man and animal. Human alphaherpes-
viruses are the herpes simplex virus type 1 (HSV-1) and 2 (HSV-2),
and the varicella zoster virus (VZV). The alphaherpesviruses also
contain different important animal pathogens, such as pseudorabies
virus (PRV), equine herpesvirus type 1 (EHV-1), and bovine herpes-
virus-1 (BoHV-1). VZV, PRV, EHV-1, and BoHV-1 all belong to the
Varicellovirus genus, the largest subgroup of the alphaherpesviruses.
A typical characteristic of herpesviruses is that they achieve
lifelong persistence in their hosts by establishing latency from which
the virus can reactivate upon speciﬁc stimuli. Reactivationmay lead to
spread of infectious virus and disease symptoms (e.g. shingles for
VZV) (Loch and Tampe, 2005; Pomeranz et al., 2005). In order to be
able to spread during reactivation periods, herpesviruses have
evolved diverse strategies to limit their recognition and subsequent
elimination by the immune system, thus enabling the virus to
replicate, spread, and transmit to other hosts. Many herpesvirusesDeruelle),
ans.Nauwynck@UGent.be
. Mettenleiter),
ll rights reserved.avoid or delay elimination by CD8+ cytotoxic T-lymphocytes (CTLs)
by interfering with the cellular MHC I antigen-processing pathway,
which is responsible for the presentation of endogenous antigens, like
viruses, to CTLs (Abele and Tampe, 2006; Lilley and Ploegh, 2005; Loch
and Tampe, 2005). For the varicelloviruses, two viral proteins have
been described to interfere with MHC I antigen-processing and MHC I
cell surface expression. For BoHV-1, PRV, and EHV-1, but not for VZV,
UL49.5 has been described to inactivate the transporter associated
with antigen-processing (TAP), thereby preventing the loading of
MHC I molecules with antigenic peptides in the endoplasmatic
reticulum and consequently downregulating MHC I cell surface
expression (Koppers-Lalic et al., 2005; Koppers-Lalic et al., 2008).
For VZV, although binding to TAP, UL49.5 does not appear to interfere
with the MHC I antigen presentation pathway (Eisfeld et al., 2007;
Koppers-Lalic et al., 2008). To date, VZV is the only alphaherpesvirus
where the viral US3 serine/threonine protein kinase orthologue
(ORF66) has been described to mediate downregulation of MHC I
from the cell surface, possibly by delaying the transport of the MHC I:
peptide complex from the ER to the trans-Golgi network (Abendroth
et al., 2001; Eisfeld et al., 2007).
In the current study, we examined PRV-mediated cell surface MHC
I downregulation in different porcine cell types. We report that the
US3 orthologue of PRV is required, but not sufﬁcient, for MHC I
downregulation in swine testicle (ST) cells. However, themechanisms
of PRV-mediated cell surface MHC I downregulation are highly cell-
Fig. 1. PRV-mediated downregulation of cell surface MHC I in ST cells depends on the
US3 protein. (A) Relative cell surface expression of MHC I (▲) and porcine pan-tissue
marker (■) at different time points after PRV inoculation of ST cells. At the indicated
hpi, expression was determined by immunoﬂuorescence staining and subsequent
analysis by ﬂow cytometry. The surface expression of both MHC I and porcine pan-
tissue marker molecules at the time of inoculation (0 hpi) was set to 100%. (B)
Relative MHC I expression on the cell surface of ST cells infected with the indicated
viruses (mock set to 100%). At 15 hpi, MHC I cell surface expression was determined
by ﬂow cytometry. Data represent the mean and standard deviation of three
independent assays. Percentages indicated by the same letter do not signiﬁcantly
differ by the ANOVA post hoc Bonferroni test (α=0.05). (C) For each condition in
panel B, US3 and UL49.5 expression at 15 hpi was veriﬁed by Western blot analysis.
gE was used as an infection control and actin as a loading control. PRV US3 exists as
two isoforms, a long and a short isoform, only differing by the presence of a 54 amino
acid N-terminal mitochondrial localization signal in the long isoform (Calton et al.,
2004; Van Minnebruggen et al., 2003). The UL49.5 glycoprotein is synthesized as a
12-kDa precursor protein, which becomes O-glycosylated to a 14-kDa mature protein
(Jons et al., 1996).
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unidentiﬁed early viral proteins.
Results
PRV-mediated downregulation of cell surface MHC I in ST cells depends
on the US3 protein
Cell surface expression of MHC I and, as a control, a porcine pan-
tissue marker molecule was determined by ﬂow cytometry at
different time points during PRV infection of ST cells. PRV-mediated
surface MHC I downregulation was observed relatively early in
infection (≤6 hpi) and progressed from that time point onwards.
The surface expression of a porcine pan-tissue marker that has been
used previously as a control in MHC I downregulation experiments
(Ambagala et al., 2000) remained largely unaffected, indicating
that PRV speciﬁcally downregulates cell surface MHC I molecules
(Fig. 1A).
To analyze a potential involvement of UL49.5 and/or US3 in PRV-
mediated MHC I downregulation in ST cells, cells were either mock-
infected, or infected with US3null PRV, UL49.5null PRV or the
corresponding isogenic parental wild-type (WT) strain. Fig. 1B
shows the relative MHC I cell surface expression at 15 hpi in infected
cells compared to mock-infected cells (set to 100%). WT PRV infection
of ST cells resulted in a 40%–45% reduction in cell surface MHC I
expression. MHC I expression on UL49.5null PRV-infected ST cells was
not signiﬁcantly higher than on isogenic WT PRV-infected cells. In
contrast, a US3null PRV showed no MHC I downregulation at all. As a
control, an isogenic US3 rescue virus behaved like WT PRV (data not
shown). Western blot analysis was performed to conﬁrm the
expression of viral proteins gE, US3, and UL49.5 in cells infected
with the different viruses (Fig. 1C). Hence, these data show that US3 is
required for cell surface MHC I downregulation during PRV infection
of ST cells.
US3-mediated downregulation of cell surface MHC I during PRV infection
of ST cells depends on the kinase activity of US3 and is not caused by
general MHC I degradation
Since the US3 protein is a serine/threonine kinase, we investi-
gated the importance of its kinase activity in downregulating cell
surface MHC I in ST cells. MHC I cell surface expression was
determined at 15 hpi in ST cells infected with either WT PRV or the
following isogenic viruses: a US3null PRV, a PRV expressing a kinase-
dead US3[D223A], or a US3 rescue PRV. The kinase-dead US3[D223A]
virus encodes an aspartate to alanine substitution at position 223,
which is conserved in serine/threonine kinases and constitutes the
catalytic base required for phosphotransfer (Hanks and Hunter,
1995). This mutant has been used earlier to determine involvement
of the kinase activity of US3 in viral axonal transport (Coller and
Smith, 2008) and modulation of the actin cytoskeleton (Van den
Broeke et al., 2009). Comparing MHC I surface expression levels to
mock-infected cells (set to 100%), both US3null PRV and kinase-dead
US3[D223A] PRV were unable to induce MHC I downregulation,
whereas both WT PRV and US3 rescue PRV efﬁciently downregulated
cell surface MHC I (Fig. 2A). Western blot analysis conﬁrmed the
expression of viral proteins gE and US3 in ST cells infected with the
different viruses (Fig. 2B).
To determine whether US3-mediated MHC I downregulation in
ST cells is caused by general MHC I degradation, ST cells were mock-
infected or infected with either WT PRV or the isogenic US3null PRV
or US3rescue PRV and analyzed at 15 hpi by Western blot for the
expression of MHC I and, as a control, viral protein gE and actin
(Fig. 2C). All cells showed similar levels of total MHC I, indicating that
US3-mediated downregulation of cell surface MHC I in ST cells is not
caused by a general degradation of MHC I.Taken together, these data demonstrate that the kinase activity
of US3 is required for cell surface MHC I downregulation during PRV
infection of ST cells, and that US3 does not lead to overall MHC I
degradation.
Fig. 2. US3-mediated downregulation of cell surface MHC I during PRV infection of ST
cells depends on the kinase activity of US3 and is not caused by general MHC I
degradation. (A) Relative cell surface expression of MHC I on ST cells infected with the
indicated viruses (mock set to 100%). At 15 hpi, MHC I expression was determined by
ﬂow cytometry. Data represent the mean and standard deviation of three independent
assays. Percentages indicated by the same letter do not signiﬁcantly differ by the
ANOVA post hoc Bonferroni test (α=0.05). (B) For each condition in panel A, US3
expression at 15 hpi was veriﬁed by Western blot analysis. gE was used as an infection
control and actin as a loading control. (C) Western blot analysis of total MHC I
expression at 15 hpi in ST cells that were either mock-infected or infected with the
indicated viruses. Expression of gE served as an infection control and actin as a loading
control. HC: heavy chain.
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PRV US3 exists as two isoforms, a long and a short isoform, only
differing by the presence of a 54 amino acid N-terminal mitochondrial
localization signal in the long isoform (Calton et al., 2004; Van
Minnebruggen et al., 2003). To investigate whether US3 is able to alter
the MHC I surface expression in the absence of other viral proteins,eukaryotic expression vectors encoding either both the PRV US3 long
and short isoforms (pKG1) or the PRV US3 short isoform (pKG2) were
transiently co-transfected with a GFP-encoding control plasmid
(pTrip) in ST cells. GFP expression was used to identify transfected
cells. Control immunoﬂuorescence experiments on permeabilized co-
transfected cells showed that over 90% of the GFP-positive cells
expressed US3 (data not shown). Both US3-encoding plasmids have
been described and used before (Deruelle et al., 2007; Geenen et al.,
2005; Van den Broeke et al., 2009). Flow cytometric analysis of GFP-
positive cells revealed that at 24 h post-transfection, MHC I and
porcine pan-tissue marker expression were not affected by either of
the US3 constructs compared to control cells that were transfected
with the GFP-encoding pTrip plasmid alone (set to 100%) (Fig. 3A).
US3 expression was veriﬁed by Western blot analysis (Fig. 3B). Flow
cytometric analysis showed that US3 expression levels in US3-
transfected cells were not lower than in PRV-infected cells, demon-
strating that the lack of MHC I downregulation in the US3-transfected
cells was not due to lower US3 expression levels in these cells
compared to PRV-infected cells (Fig. 3C).
These data show that PRV US3 is unable to reduce MHC I cell
surface expression in ST cells in the absence of other viral proteins,
and thus that additional, possibly US3-phosphorylated, viral proteins
are involved in reducing MHC I levels on PRV-infected ST cells.
PRV-mediated downregulation of cell surface MHC I in PK-15 cells partly
depends on UL49.5 but does not depend on US3
In PK-15 cells, similar as observed for ST cells, PRV was found to
speciﬁcally downregulate cell surface MHC I, starting ≤6 hpi and
progressing from that time point onwards (Fig. 4A). Again, the ability
to downregulate MHC I cell surface expression was analyzed for a
UL49.5null PRV, a US3null PRV, and the respective WT PRV strains at
15 hpi. MHC I cell surface levels were compared to mock-infected
PK-15 cells (set to 100%). WT PRV infection resulted in a 60%–65%
reduction of MHC I cell surface expression. The UL49.5null PRV was
partially impaired in downregulating MHC I, whereas the US3null
PRV was not impaired in MHC I cell surface downregulation. A
UL49.5 rescue virus behaved like WT virus (Fig. 4B). Expression of
gE, US3, and UL49.5 was veriﬁed by Western blot analysis (Fig. 4C).
These data indicate that, in PK-15 cells, UL49.5 and additional, yet
unidentiﬁed viral proteins are involved in MHC I cell surface
downregulation.
UL49.5 and US3 are not involved in PRV-mediated downregulation of
cell surface MHC I in porcine alveolar macrophages (PAM)
Since the mechanism of PRV-mediated MHC I downregulation
was different in ST versus PK-15 cells, additional experiments were
performed in a third cell type: primary porcine alveolar macro-
phages (PAM). Like in ST and PK-15 cells, PRV was found to
speciﬁcally and progressively downregulate cell surface MHC I in
PAM from ≤6 hpi onwards (Fig. 5A). MHC I cell surface expression in
PAM infected with UL49.5null PRV, US3null PRV or the
corresponding isogenic WT PRV strains was analyzed at 15 hpi and
compared to mock-infected PAM (set to 100%). WT PRV-infected
PAM showed a 40%–50% MHC I downregulation. A US3null PRV
resulted in a similar MHC I downregulation as its isogenic WT PRV,
whereas a UL49.5null PRV showed a slight, but statistically
insigniﬁcant, decrease in MHC I downregulating capacity compared
with the corresponding WT PRV (Fig. 5B). MHC I downregulation
was observed in different batches of primary PAM, i.e., macrophages
derived from a different porcine source, albeit with slight differences
in efﬁciency. Batch differences likely explain the slight differences in
efﬁciency of MHC I downregulation observed in Fig. 5A versus
Fig. 5B. Expression of gE, US3, and UL49.5 was veriﬁed by Western
blot analysis (Fig. 5C). Thus, in PAM, PRV-mediated downregulation
Fig. 3. Kinase-intact PRV US3 is necessary but not sufﬁcient to downregulate cell surface MHC I in ST cells. (A) Relative cell surface expression of MHC I (white bars) and porcine pan-
tissue marker (ﬁlled bars) on ST cells that were transiently co-transfected with a GFP-encoding control plasmid (pTrip) and a eukaryotic expression vector encoding either the PRV
US3 long and short isoforms (pKG1) or the short isoform (pKG2). Flow cytometric analysis of GFP-positive cells was performed at 24 h post-transfection (hpt). The surface
expression of MHC I and porcine pan-tissue marker molecules on ST cells that were transiently transfected with pTrip alone was set to 100%. (B) US3 expression in the conditions
described in panel A was veriﬁed at 24 hpt byWestern blot analysis. Actin was used as a loading control. (C) US3 expression levels in PRV-infected and pKG1 or pKG2-transfected ST
cells as determined by ﬂow cytometry at 15 hpi or 24 hpt, respectively.
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UL49.5 and US3.
UL49.5 and US3 expression kinetics are similar in ST cells, PK-15 cells,
and PAM
In order to analyze whether the observed cell type variability was
due to differential expression kinetics of UL49.5 and US3 in the
different cell types, expression of these proteins during PRV infection
of either cell type was analyzed by Western blot (Fig. 6). Expression
kinetics were largely similar in all cell types tested. The US3 short
isoform, an early protein, was expressed earlier than the US3 long
isoform and UL49.5 in all cell types. Expression of UL49.5 was similar
to that of gE, another viral envelope protein, and therefore appears
to behave as a typical structural envelope protein. In addition, UL49.5
and US3 long isoform expression were strongly (ST and PK-15 cells)
or completely (PAM) reduced upon phosphono-acetic acid (PAA)treatment, indicating that both UL49.5 and the US3 long isoform
largely behave as late proteins in all cell types used. In conclusion, it
appears unlikely that the observed cell-type-dependent differences
in MHC I downregulation mechanisms are due to differential
expression patterns of UL49.5 and US3 in different cell types.
Early viral protein(s) are involved in PRV-mediated downregulation of
cell surface MHC I in PK-15 cells and PAM
Since downregulation of cell surface MHC I in PK-15 cells and
PAM was (partly) independent of UL49.5 and independent of US3,
we tried to identify the time frame in which the unidentiﬁed
additional viral protein(s) are expressed. In a ﬁrst step, by
inoculating PK-15 cells and PAM with UV-inactivated PRV, it was
examined whether de novo viral protein synthesis is required for cell
surface MHC I downregulation in these cells. In PK-15 cells, MHC I
cell surface expression levels in cells inoculated with UV-inactivated
Fig. 4. PRV-mediated downregulation of cell surface MHC I in PK-15 cells partly
depends on UL49.5 but does not depend on US3. (A) Relative cell surface expression of
MHC I (▲) and porcine pan-tissue marker (■) at different time points after PRV
inoculation of PK-15 cells. At the indicated hpi, expression was determined by
immunoﬂuorescence staining and subsequent ﬂow cytometric analysis. The surface
expression of MHC I and porcine pan-tissue marker molecules at the time of inoculation
(0 hpi) was set to 100%. (B) Relative MHC I expression on the cell surface of PK-15 cells
infected with the indicated viruses (mock set to 100%). At 15 hpi, MHC I cell surface
expression was determined by ﬂow cytometry. Data represent the mean and standard
deviation of three independent assays. Percentages indicated by the same letter do not
signiﬁcantly differ by the ANOVA post hoc Bonferroni test (α=0.05). (C) For each
condition from panel B, US3 and UL49.5 expression at 15 hpi was conﬁrmed byWestern
blot analysis. gE was used as an infection control and actin as a loading control.
Fig. 5. PRV-mediated downregulation of cell surface MHC I in PAM is both US3- and
UL49.5-independent. (A) Relative cell surface expression of MHC I (▲) and porcine pan-
tissue marker (■) at different time points after PRV inoculation of PAM shows an MHC
I-speciﬁc downregulation. At the indicated hpi, expression was determined by
immunoﬂuorescence staining and subsequent ﬂow cytometric analysis. The surface
expression of both MHC I and porcine pan-tissue marker molecules at the time of
inoculation (0 hpi) was set to 100%. (B) Relative MHC I expression on the cell surface of
PAM infected with the indicated viruses (mock set to 100%). At 15 hpi, MHC I cell
surface expression was determined by ﬂow cytometry. Data represent the mean and
standard deviation of three independent assays. Percentages indicated by the same
letter do not signiﬁcantly differ by the ANOVA post hoc Bonferroni test (α=0.05). (C)
For each condition in panel B, US3 and UL49.5 expression at 15 hpi was conﬁrmed by
Western blot analysis. gE was used as an infection control and actin as a loading control.
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100%) (Fig. 7A). Interestingly, in PAM, UV-inactivated PRV induced a
signiﬁcant MHC I upregulation at the cell surface (Fig. 7B). Hence, de
novo viral protein synthesis is required for cell surface MHC I
downregulation in both PK-15 cells and PAM. In a second step, it was
determined whether early or late viral proteins are involved. In order
to inhibit the synthesis of late viral proteins, PK-15 cells and PAM
were WT PRV-infected in either the absence or the presence of
250 μg ml-1 PAA. In PAM, PAA treatment did not affect the ability of
PRV to downregulate MHC I cell surface expression compared tountreated PRV-infected cells (Fig. 7B), indicating that one or more
early viral proteins are involved in the PRV-mediated MHC I
downregulation in PAM. In PK-15 cells, PAA treatment partly
increased MHC I cell surface expression compared to untreated
PRV-infected cells, but this was still substantially lower than MHC I
expression on mock-infected PK-15 cells (Fig. 7A). This indicates
that, also in PK-15 cells, a large fraction of the PRV-mediated cell
surface MHC I downregulation depends on one or more viral early
Fig. 6. UL49.5 and US3 expression patterns are similar in ST cells, PK-15 cells, and PAM. ST cells, PK-15 cells, and PAM were WT PRV-infected, either in the absence or presence of
250 μg ml-1 PAA. Expression of US3, UL49.5, and gE at the indicated time points post-inoculation was analyzed by Western blot. Actin was used as a loading control.
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early viral protein(s) is required for efﬁcient MHC I downregulation
from the cell surface in both PAM and PK-15.Fig. 7.De novo protein synthesis of additional and yet unidentiﬁed early viral protein(s)
is involved in PRV-mediated downregulation of cell surface MHC I in PK-15 cells and
PAM. PK-15 cells (A) and PAM (B) were either mock-infected, infected with a UV-
inactivated WT PRV, or infected with WT PRV in either the absence or presence of
250 μg ml-1 PAA. At 15 hpi, MHC I cell surface expression was determined by ﬂow
cytometry (mock set to 100%). Data represent themean and standard deviation of three
independent assays. Percentages indicated by the same letter do not signiﬁcantly differ
by the ANOVA post hoc Bonferroni test (α=0.05).Discussion
The results presented in the current study show that the US3
protein of PRV is required for downregulation of MHC I from the cell
surface of infected ST cells but highlight that the mechanisms of PRV-
mediated cell surface MHC I downregulation are highly cell-type-
dependent.We found that a kinase-intact PRV US3 protein is required,
but not sufﬁcient, to reduce MHC I expression on the cell surface of ST
cells. In contrast, US3 was not required for MHC I downregulation in
PK-15 cells or PAM. PRV-mediated cell surface MHC I downregulation
was partially dependent on the UL49.5 glycoprotein in PK-15 cells,
whereas UL49.5 was not required for downregulation of MHC I in both
ST cells and PAM.
Downregulation and modulation of cell surface MHC I during PRV
infection have been reported before on PK-15 cells (Ambagala et al.,
2003; Ambagala et al., 2000) and murine cells (Mellencamp et al.,
1991; Sparks-Thissen and Enquist, 1999). Before this study, VZV was
the only alphaherpesvirus for which the US3 orthologue (ORF66) has
been described to interfere with MHC I-restricted antigen presenta-
tion and MHC I cell surface expression (Abendroth et al., 2001; Eisfeld
et al., 2007). In line with our data on ST cells, Eisfeld et al. (2007)
reported that the ORF66-mediated MHC I downregulation was
predominantly kinase-dependent. In contrast to our current data on
PRV US3, however, a kinase-dead ORF66 VZV still retained some
ability to downregulate MHC I cell surface expression (Eisfeld et al.,
2007). In further support of mechanistic differences in activity of PRV
US3 and VZV ORF66 regarding MHC I downregulation is our ﬁnding
that transfection of PRV US3 did not result in cell surface MHC I
downregulation. VZV ORF66, on the other hand, has been reported to
result in a signiﬁcant reduction in MHC I cell surface expression upon
transfection or transduction in ﬁbroblasts (Abendroth et al., 2001;
Eisfeld et al., 2007). Hence, VZV ORF66 interacts with, and most likely
phosphorylates, a cellular protein either directly or indirectly
interfering with the antigen-processing pathway, thereby impairing
the MHC I transport from the ER to the trans-Golgi network (Eisfeld et
al., 2007). Based on our observation that PRV US3 is unable to
downregulate MHC I in the absence of other viral proteins, we suggest
that US3 either (i) phosphorylates another viral protein that (in)
directly interacts with a cellular protein involved in MHC I antigen
presentation or (ii) phosphorylates a cellular protein (in)directly
involved in MHC I antigen presentation that may then be targeted or
blocked by another viral protein during infection.
In agreement with a previous report (van Zijl et al., 1990), the
expression of the PRV US3 long isoform showed a 4- to 6-h retardation
compared to the short isoform in all cell types and was blocked in the
presence of PAA (Fig. 6). Combined with our observation that PAA
addition did not alter the level of MHC I downregulation during PRV
infection in ST cells (data not shown), this indicates that the PRV US3
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in MHC I surface expression in ST cells.
It will be interesting to further dissect the mechanism and the
relevance of the phosphorylation-mediated downregulation of MHC I
by US3 in ST cells. Phosphorylation of different proteins involved in
the MHC I antigen presentation pathway, including TAP and MHC I
itself, may affect MHC I cell surface expression and efﬁcient antigen
presentation (Basha et al., 2008; Li et al., 2000). Indeed, although
phosphorylated TAP is able to bind both ATP and peptides, it is unable
to transport peptides to the ER, resulting in a reduced MHC I cell
surface expression (Li et al., 2000). In addition, in transgenic mice
expressing MHC I molecules lacking conserved phosphorylation sites
in their cytoplasmic domain, MHC I molecules are internalized less
efﬁciently from the cell surface compared to mice expressing WT
MHC I (Basha et al., 2008). Virus-mediated phosphorylation events
in MHC I downregulation have been described before. For human
immunodeﬁciency virus type 1 (HIV-1), it has been shown that
MHC I downregulation by the viral Nef protein is mediated by the
assembly and activation of a cellular multikinase cascade involving a
Src tyrosine family kinase, ZAP-70/Syk kinase, and class I phosphoi-
nositide-3 kinase (Atkins et al., 2008; Hung et al., 2007). It has also
been suggested that phosphorylation of the 72-kDa human cyto-
megalovirus (HCMV) IE1 transcription factor by the viral pp65
matrix protein kinase limits proteasomal processing of IE1 and thus
antigen presentation (Gilbert et al., 1996).
Is it possible that US3 and UL49.5 cooperate in some way during
MHC I downregulation? Based on our current data, this appears
unlikely. Indeed, if UL49.5 and US3 were to cooperate, one would
expect that both UL49.5null and US3null PRV would be (partially)
impaired in downregulating MHC I from the cell surface, which is not
in linewith our results, wherewe either see a requirement for US3 but
not UL49.5 (ST), a partial requirement for UL49.5 but not US3 (PK-15)
or no requirement for either protein (PAM). Hence, we hypothesize
that US3 and UL49.5 act on different aspects of the MHC I antigen-
processing pathway in an unrelated manner. Nevertheless, at present,
we cannot formally exclude the possibility of cooperation between
UL49.5 and US3. Future research will clarify this issue, e.g., by
investigating MHC I downregulating capacity of a US3null/UL49.5null
PRV double mutant.
We noticed somewhat decreased expression levels of UL49.5 in
US3null PRV-infected cells versusWT PRV-infected cells (e.g., Figs. 1C,
4C, 5C). This slight decrease is most likely due to the slight growth
retardation of US3null PRV compared to WT PRV, as we and others
observed previously in 1-step growth curves (e.g., Coller and Smith,
2008; Kimman et al., 1994; Van den Broeke et al., 2009). Kinetic
analysis of the expression levels of UL49.5 and, as a control, gE indeed
conﬁrmed a ±2-h retardation in viral protein expression of both
UL49.5 and gE in US3null PRV-infected cells (data not shown). The
slight reduction in UL49.5 in US3null PRV-infected cells is unlikely to
substantially affect MHC I downregulation. Indeed, in ST cells, US3null
PRV failed to downregulate MHC I (Fig. 1). If this were due to the
slightly lower level of UL49.5 observed with this virus, one would
expect that a UL49.5null PRV also fails to downregulate MHC I, which
is not the case (Fig. 1).
Although expression kinetics of US3 and UL49.5 were largely
similar in all cell types tested, expression of UL49.5 was slightly
delayed in ST cells and PAM compared to PK-15 cells, whereas US3
expression was slightly delayed in PK-15 cells and PAM (Fig. 6).
Although the differences in expression kinetics of both US3 and
UL49.5 between the different cell types are very small compared to
the manifest differences in MHC I downregulation mechanisms, it
may be interesting to further investigate whether these slight
differences in expression kinetics may have some effect on the cell-
type-dependent mechanism of MHC I downregulation.
Besides the differences in mechanism of MHC I downregulation
between US3 of PRV (current study) and ORF66 of VZV (Abendrothet al., 2001; Eisfeld et al., 2007), other studies have shown that
different orthologues of UL49.5, the other Varicellovirus protein that
has been described to interfere with MHC I cell surface expression,
also appears to act differently in closely related viruses: via
inhibition of ATP binding to the nucleotide binding domain of TAP
(EHV-1), degradation of TAP by mediating its targeting to the
ubiquitin–proteasome pathway (BoHV-1), and/or arresting TAP in a
translocation incompetent conformation (BoHV-1, PRV, and EHV-1)
(Koppers-Lalic et al., 2008). These observations probably stress the
importance for the virus to develop multiple strategies in order to
interfere with the generation and/or presentation of antigenic
peptide fragments to CTLs. Members of the beta- and gammaher-
pesvirus subfamilies also have evolved multiple and extremely
diverse strategies to downregulate surface MHC I, by interacting
with either TAP or other components of the MHC I antigen
presentation pathway (Abele and Tampe, 2006; Lilley and Ploegh,
2005; Loch and Tampe, 2005). Our current ﬁnding that PRV
downregulates MHC I differently in different cell types, and thus
that the cellular environment may determine which viral MHC I-
interfering mechanism is functional, may represent one hypothetical
explanation for this diversity in mechanisms that herpesviruses have
evolved to downregulate cell surface MHC I. This might be related to
the fact that MHC-encoding genes are extremely polymorphic,
possibly due to host–pathogen coevolution (Borghans et al., 2004;
De Boer et al., 2004). Indeed, it has been demonstrated for several
viruses, including PRV, mouse hepatitis virus, adenovirus, HSV, and
HCMV, that MHC I proteins derived from different alleles may show
a differential regulation and sensitivity towards immunoevasion
upon viral infection (Beier et al., 1994; Hill et al., 1994; Machold et al.,
1997; Sparks-Thissen and Enquist, 1999).
It has been shown earlier that transduction of PRV UL49.5 in PK-
15 cells reduced cell surface MHC I expression (Koppers-Lalic et al.,
2008). This is in line with the current report, which extends these
ﬁndings by demonstrating that UL49.5 also downregulates MHC I in
PK-15 cells during natural PRV infection. However, our ﬁndings
indicate that besides UL49.5, additional yet unidentiﬁed early
proteins other than US3 are also involved in MHC I downregulation
in PRV-infected PK-15 cells. This may correlate with earlier reports
showing that during PRV infection of PK-15 cells, UL49.5 is involved
in, but not solely responsible for, inhibition of TAP activity (Koppers-
Lalic et al., 2005; Koppers-Lalic et al., 2008). It also appears that the
UL49.5 protein has different expression kinetics in different
varicelloviruses. For BoHV-1, UL49.5 expression has been reported
to be unaffected by the late protein synthesis inhibitor PAA
(Lipinska et al., 2006), whereas in the current report, we found
that PAA strongly reduced the expression of UL49.5 in all cell types
tested (Fig. 6), indicating that in PRV, UL49.5 does not behave as a
typical early viral protein.
Since PRV-mediated cell surface MHC I downregulation in PK-15
cells and PAMwas independent of US3 and was only partially (PK-15)
or not (PAM) dependent on UL49.5, we tried to identify the time
frame in which the unidentiﬁed additional viral protein(s) are
expressed. First, we found that PRV-mediated cell surface MHC I
downregulation is dependent on de novo viral protein synthesis, since
UV-inactivated virus was unable to downregulate cell surface MHC I.
This is in agreement with previous reports on PRV (Ambagala et al.,
2000), BoHV-1 (Koppers-Lalic et al., 2001), EHV-1 (Ambagala et al.,
2004; Rappocciolo et al., 2003), and feline herpesvirus type 1 (FHV-1)
(Montagnaro et al., 2009). Interestingly, whereas surface MHC I
expression in ST (data not shown) and PK-15 cells was unaffected
upon inoculation with UV-inactivated PRV, a signiﬁcant MHC I
upregulation was observed in PAM. This may correlate with earlier
ﬁndings that UV-inactivated HSV-1 upregulated, in addition to CD80
and CD86, MHC I expression in dendritic cells, which are, like
macrophages, antigen presenting cells (Jones et al., 2003). Second,
since infection in the presence of PAA did only partially (PK-15) or not
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largely depends on early viral protein synthesis. The involvement of
early PRV proteins in MHC I downregulation from the cell surface
corresponds with the observation that PRV infection resulted in a
progressive downregulation of MHC I starting ≤6 hpi in all cell types
tested. This is also in line with previous reports on PRV (Ambagala et
al., 2000; Sparks-Thissen and Enquist, 1999), BoHV-1 (Koppers-Lalic
et al., 2001), VZV (Abendroth et al., 2001), and EHV-1 (Ambagala et al.,
2004; Rappocciolo et al., 2003). Recently, it has also been shown that
early proteins are responsible for MHC I downregulation in FHV-1-
infected cells (Montagnaro et al., 2009).
In the current report, we show that PRV US3 is able to interfere
with MHC I-restricted antigen presentation and that downregulation
of cell surface MHC I in PRV-infected cells is not restricted to UL49.5.
Since it is often difﬁcult to extrapolate data from immortalized cell
cultures to the in vivo situation, it will be crucial to further analyze the
mechanism of PRV-mediated MHC I downregulation in different
relevant primary cell types. Our current ﬁnding that cell surfaceMHC I
downregulation in PAM does not require UL49.5, nor US3 underscores
the importance of a continued search for viral proteins that interfere
with MHC I in primary cell types.
In conclusion, we report that the US3 orthologue of PRV is
required, but not sufﬁcient, for MHC I downregulation in ST cells.
However, the mechanisms of PRV-mediated MHC I cell surface
downregulation are highly cell-type-dependent, with variable roles
for US3, UL49.5, and additional, unidentiﬁed early viral proteins.
Material and methods
Antibodies, chemicals, and other reagents
Mouse monoclonal antibody PT85A directed against the heavy
chain of MHC I was purchased from VMRD. Anti-porcine pan-tissue
marker monoclonal antibody 1030h-1-19 (Ambagala et al., 2000) was
obtained from Dr. D.H. Sachs (Massachusetts General Hospital,
Boston). Lipofectamine and both Cy5- and ﬂuorescein isothiocyanate
(FITC)-labeled goat anti-mouse antibodies were from Invitrogen.
Mouse monoclonal antibody 18E8 against PRV gE and FITC-labeled
polyclonal porcine anti-PRV antibodies were described earlier
(Nauwynck and Pensaert, 1995). A US3-speciﬁc mouse monoclonal
antibody was kindly provided by LeighAnne Olsen and Lynn Enquist
(Princeton University, USA), and a rabbit anti-PRV UL49.5 serum was
obtained from Barbara Klupp and Thomas Mettenleiter (Institute of
Molecular Biology, Friedrich-Loefﬂer-Institut, Germany). Rabbit anti-
actin antibody, saponin, and phosphonoacetic acid (PAA) were from
Sigma-Aldrich. HRP-conjugated goat anti-rabbit and goat anti-mouse
antibodies were purchased from DakoCytomation, and both Hybond-
P PVDF membrane and enhanced chemiluminescence (ECL) reagents
from GE Healthcare. NP-40 and protease inhibitor cocktail were from
RocheDiagnostics. BCA Protein Assay Reagent was purchased from
Pierce Biotechnology.
Cells, viruses, and inoculation
Porcine kidney PK-15 cells were cultured in Eagle's minimal
essential medium supplemented with 10% fetal calf serum (FCS),
0.3 mg ml-1 glutamine, 100 U ml-1 penicillin, 0.1 mg ml-1
streptomycin, and 0.05 mg ml-1 gentamycin. ST cells were cultured
in PK-15 medium supplemented with 1 mM sodium pyruvate. PAM
were derived from lung lavages of 3- to 4-week-old piglets as
described before (Wensvoort et al., 1991) and were cultured in RPMI
medium supplemented with 10% FCS, 0.3 mg ml-1 glutamine, 1 mM
sodium pyruvate, 1× MEM non-essential amino acids, 100 U ml-1
penicillin, 0.1 mg ml-1 streptomycin, 0.1 mg ml-1 gentamycin, and
0.1 mg ml-1 kanamycin. All cells were grown in 6-well plates (Nunc)
at 37 °C in a humidiﬁed incubator containing 5% CO2.WT and mutant PRV Nia3, Kaplan and Becker strains were used.
US3null PRV Nia3 (M118), US3 rescue PRV Nia3 (M120), and VHSnull
PRV Nia3 were kindly provided by the ID-DLO Institute in The
Netherlands. These US3null and VHSnull Nia3 mutants were con-
structed by insertion of a palindromic oligonucleotide containing
translational stop codons in all reading frames, in the 5′ part of the
open reading frame (ORF) (de Wind et al., 1990). UL49.5null PRV
Kaplan and the rescue virus have been described earlier (Jons et al.,
1998). In brief, the UL49.5null Kaplan mutant was obtained by
deleting a 24-bp fragment within the UL49.5 gene and the
concomitant insertion of a 3.6-kb gG-β-Gal expression cassette
(Jons et al., 1998). US3null PRV Becker and kinase-dead US3[D223A]
PRV Becker were kindly provided by Greg Smith (Northwestern
University, Chicago, USA). US3null Becker (PRV-GS1015) was con-
structed by replacing a large part of the US3 ORF with a TAA stop
codon (Antinone et al., 2006), and the Becker mutant encoding the
catalytically inactive US3 kinase (PRV-GS976) was made by intro-
ducing a point mutation that results in the substitution of an alanine
in place of an aspartate at position 223 in the US3 ORF (Coller and
Smith, 2008). A recently constructed rescue virus of the kinase-dead
US3 PRV Becker strain was also used (Van den Broeke et al., 2009).
PK-15 and ST cells were grown to conﬂuency prior to infection,
PAM were seeded at 3.106 well-1. All cell types were mock-
inoculated or inoculated with either of the PRV strains at a
multiplicity of infection of 10 in a total volume of 1 ml culture
medium. When ultraviolet (UV)-inactivated PRV was used, inacti-
vation was performed by UV irradiating the WT Nia3 inoculum in a
petriplate on ice (thickness of virus suspension was 1.5–2 mm) with
1000 mJ cm-2, using a CL-1000 UV Crosslinker (UVP, Inc.). For
infections in the presence of PAA, a ﬁnal concentration of 250 μg ml-1
PAA was used.
Transfections
US3-encoding plasmids pKG1 and pKG2 (Geenen et al., 2005)
were transiently co-transfected in a 1:1 ratio with the GFP-encoding
control plasmid pTrip (obtained from Bruno Verhasselt, Ghent
University, Belgium) in ST cells grown to 60%–70% conﬂuency, using
Lipofectamine according to the manufacturer's instructions (Invitro-
gen). ST cells transfected with pTrip alone were used as reference for
both MHC I and porcine pan-tissue marker molecule expression.
Immunoﬂuorescence staining of MHC I, porcine pan-tissue marker
molecule, and PRV antigens at the cell surface
ST cells, PK-15 cells, and PAM were detached by trypsinization
(PK-15 and ST cells) or pipetting (PAM) at the indicated hours post-
inoculation (hpi) or 24 h post-transfection (hpt), washed in ice-cold
PBS, ﬁxed in 3% paraformaldehyde for 10 min at room temperature,
and ﬁnally washed twice in PBS. PAM, but not ST or PK-15 cells, were
then pre-incubated for 30 min in 10% negative goat serum in PBS in
order to block Fc receptors. Subsequently, cells were stained for either
MHC I or porcine pan-tissue marker molecules at the cell surface,
using mouse anti-MHC I (1/200) or mouse anti-porcine pan-tissue
marker (1/100) as primary antibodies, respectively, followed by a
secondary incubation with a Cy5-conjugated goat anti-mouse
antibody (1/200). PRV cell surface antigens were visualized using
FITC- labeled polyclonal porcine anti-PRV antibodies (1/200). All
antibody dilutions were made in 10% negative goat serum in PBS, and
all antibody incubations were done for 1 h at 37 °C. Cells were washed
twice in PBS after each incubation. Analysis was done by ﬂow
cytometry. When the PRV Becker mutants were used, MHC I was
indirectly labeled with FITC instead of Cy5 to avoid interference of the
mRFP emission signal of these mutant viruses (they encode a VP26-
mRFP fusion protein) with the Cy5 emission signal in the FL-5
detector of the ﬂow cytometer.
180 M.J. Deruelle et al. / Virology 395 (2009) 172–181Immunoﬂuorescence staining of US3 in infected and transfected ST cells
ST cells were collected and ﬁxed at 15 hpi or 24 hpt as described
above. Subsequently, cells were pre-incubated for 10 min in 0.1%
saponin in PBS, and then incubated with mouse anti-US3 (1/100) and
FITC-conjugated goat anti-mouse antibody (1/200). All incubations
and washing steps were done as mentioned above, but with a ﬁnal
concentration of 0.1% saponin (in order to keep cells permeabilized).
A ﬁnal wash in PBS was performed.
Flow cytometric analysis
Median ﬂuorescence intensity of cells was determined by ﬂow
cytometry (FACSCanto, Beckton-Dickinson Biosciences), counting
10,000 cells. Excitation lasers of 488 and 633 nm were used for
FITC/GFP and Cy5, respectively. Since double stainings were
performed, infected and non-infected cells could be distinguished.
For the transfection experiments, GFP-positive cells were analyzed
for determination of MHC I and porcine pan-tissue marker surface
expression, and US3-positive cells for determination of US3
expression.
Statistical data analysis
Statistical analysis of the data was done in SPSS using the ANOVA
post hoc Bonferroni test (α=0.05).
SDS-PAGE and Western blot
PK-15 cells, ST cells, and PAM were either mock-infected, infected
with the indicated viruses, or transfected with the indicated plasmids.
At 15 hpi or 24 hpt, cells were collected on ice using a rubber
policeman, washed in TNE buffer (20 mM Tris–HCl pH 8.0, 150 mM
NaCl, 1 mM EDTA), and lysed in TNE lysis buffer (TNE with 1% NP-40,
1 mM sodium vanadate, 10 mM sodium ﬂuoride, and protease
inhibitor cocktail) for 1 h at 4 °C. Protein concentrations of cell lysates
were determined with the BCA protein assay reagent according to the
manufacturer's instructions (Pierce Biotechnology). Protein (15–
20 μg) was fractionated on a 10% (gE, US3, and actin detection) or
12% (UL49.5 and MHC I detection) polyacrylamide gel by SDS-PAGE,
and then transferred to a Hybond-P PVDF membrane. After blotting,
membranes were blocked in 5% non-fat dry milk in 0.1% TBS/Tween-
20 for 1 h at RT, and incubated with either mouse anti-gE (1/200),
mouse anti-US3 (1/2000), mouse anti-MHC I (1/500), rabbit anti-
UL49.5 (1/4000), or rabbit anti-actin (1/500) primary antibodies.
Following incubationwith the appropriate HRP-conjugated secondary
goat antibody, blots were developed by ECL. All incubation steps were
done in blocking buffer.
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